Myers, L W <br/><br/>
Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.  [electronic resource] 

 -  Neurology  Nov 1998 
 - 1483-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.51.5.1483  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Brain--pathology<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Evoked Potentials, Visual--drug effects<br/>Humans<br/>Lymphocytes--immunology<br/>Magnetic Resonance Imaging<br/>Multiple Sclerosis--drug therapy<br/>Pentoxifylline--therapeutic use<br/>Time Factors<br/>Treatment Failure<br/>Tumor Necrosis Factor-alpha--biosynthesis